“We are interested to do bolt-on acquisitions,” Mr. van Houten said, referring to when a private equity-backed company acquires another company. “Deals done last year were bolt-on, not transformational from a size point of view, but very important nuggets.”
In 2017, Philips spent roughly €2.3 billion (an estimated $2.8 billion) on acquisitions, including health IT companies like population health management company VitalHealth, interoperability software provider Forcare and image analysis software provider TomTec Imaging Systems GmbH.
The acquisitions are part of Philips’ strategy to refocus its business on healthcare equipment and services, pivoting away from the company’s traditional emphasis on being a diversified manufacturer of products spanning light bulbs, TVs and CDs.
“Doing a transformation of a company is not easy,” Mr. van Houten told Bloomberg.
Mr. van Houten said the company’s latest earnings results, released April 23, were promising. Philips posted €3.94 billion (an estimated $4.82 billion) in sales for the first quarter of 2018, including €1.53 billion (an estimated $1.87 billion) in sales for its diagnosis and treatment business segment.
More articles on health IT:
5 popular clinical process improvement vendors, as ranked by KLAS
Lancaster General Health partners with private equity firm to launch $300M precision medicine fund
Philips posts $4.8B in sales for Q1, dips 2% from 1 year prior: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
